WEBULL
News
LEXXW
0.0223
0.00%
0.00
Lexaria Bioscience Issues Warrants to Purchase 2.66 Million Shares
Reuters · 1d ago
Weekly Report: what happened at LEXXW last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at LEXXW last week (1201-1205)?
Weekly Report · 12/08 09:18
Weekly Report: what happened at LEXXW last week (1124-1128)?
Weekly Report · 12/01 09:17
Weekly Report: what happened at LEXXW last week (1117-1121)?
Weekly Report · 11/24 09:18
Weekly Report: what happened at LEXXW last week (1110-1114)?
Weekly Report · 11/17 09:18
Lexaria Extends Partnership With PharmaCO To April 2026 For Ongoing Evaluation Of DehydraTECH, Following Australian Study Data Review
Benzinga · 11/12 14:12
Lexaria Bioscience Extends Material Transfer Agreement with Pharmaceutical Company
Reuters · 11/12 14:10
Weekly Report: what happened at LEXXW last week (1103-1107)?
Weekly Report · 11/10 09:17
Weekly Report: what happened at LEXXW last week (1027-1031)?
Weekly Report · 11/03 09:17
Weekly Report: what happened at LEXXW last week (1020-1024)?
Weekly Report · 10/27 09:18
Weekly Report: what happened at LEXXW last week (1013-1017)?
Weekly Report · 10/20 09:18
Weekly Report: what happened at LEXXW last week (1006-1010)?
Weekly Report · 10/13 09:18
Lexaria Bioscience Corp. Awarded Four New Patents Covering Diabetes, Epilepsy, Antiviral Treatments, and More
Reuters · 10/09 13:20
Weekly Report: what happened at LEXXW last week (0929-1003)?
Weekly Report · 10/06 09:17
BRIEF-Lexaria Bioscience enters securities purchase agreement with investors - SEC filing
Reuters · 09/29 22:28
LEXARIA BIOSCIENCE CORP - ENTERS SECURITIES PURCHASE AGREEMENT WITH INVESTORS - SEC FILING
Reuters · 09/29 21:06
Weekly Report: what happened at LEXXW last week (0922-0926)?
Weekly Report · 09/29 09:18
Lexaria Bioscience Corp. Announces $4 Million Registered Direct Offering and Concurrent Private Placement of Warrants
Reuters · 09/26 12:00
LEXARIA BIOSCIENCE CORP - ON SEPT 19, TERMINATED CAPITAL ON DEMAND SALES AGREEMENT - SEC FILING
Reuters · 09/25 21:15
More
Webull provides a variety of real-time LEXXW stock news. You can receive the latest news about Lexaria Bioscien through multiple platforms. This information may help you make smarter investment decisions.
About LEXXW
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.